• Investors may be asking whether Omega Healthcare Investors at US$47.90 still offers value after a strong run, or if they might be late to the story.
• The stock is slightly down 0.9% over the past week, while returns sit at 3.2% over 30 days, 7.6% year to date, 40.8% over 1 year and 94.8% over 5 years. This mix often prompts investors to revisit what they are really paying for.
• Recent coverage has focused on Omega Healthcare Investors as a healthcare focused REIT, with attention on how its portfolio of skilled nursing and senior housing facilities fits into long term demographic trends and sector specific policy developments. Investors have been weighing that backdrop as they reassess the stock after a strong multi year performance.
• On Simply Wall St's 6 point valuation check, Omega Healthcare Investors scores 4 out of 6. The next step is a closer look at what different valuation approaches say about that score and how an even richer view of valuation can be built beyond the usual metrics.

Approach 1: Omega Healthcare Investors Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow, or DCF, model estimates what a stock could be worth by projecting its future adjusted funds from operations, then discounting those cash flows back to today’s value.

For Omega Healthcare Investors, the model uses a 2 stage Free Cash Flow to Equity approach based on Adjusted Funds From Operations. The latest twelve month free cash flow is around $946.16 million. Analysts and extrapolated estimates point to projected free cash flow of $1,275.87 million by 2030, with a series of annual projections between those points that are discounted to reflect the time value of money.

Putting all of those projected cash flows together, Simply Wall St’s DCF model arrives at an estimated intrinsic value of $92.49 per share. Compared with the current share price of $47.90, this suggests the stock is 48.2% undervalued using this methodology.

Result: UNDERVALUED

Our Discounted Cash Flow (DCF) analysis suggests Omega Healthcare Investors is undervalued by 48.2%. Track this in your watchlist or portfolio, or discover 48 more high quality undervalued stocks.

Approach 2: Omega Healthcare Investors Price vs Earnings

For profitable companies, the P/E ratio is a useful shorthand because it links what you pay for each share with the earnings that support that share price. It helps you compare how the market is pricing similar levels of earnings across different stocks.

What counts as a “normal” P/E depends on what investors expect for future growth and how much risk they see in those earnings. Higher expected growth or lower perceived risk can justify a higher multiple, while slower growth or higher risk usually points to a lower one.

Omega Healthcare Investors currently trades on a P/E of 23.16x, compared with the Health Care REITs industry average of about 21.74x and a peer group average of 56.84x. Simply Wall St’s Fair Ratio for Omega Healthcare Investors is 33.12x. This Fair Ratio is a proprietary estimate of what the P/E might be given factors such as earnings growth, industry, profit margins, market cap and key risks.

Because the Fair Ratio directly incorporates those company specific drivers, it offers a more tailored yardstick than a simple comparison with peers or the industry. With the current P/E at 23.16x versus a Fair Ratio of 33.12x, the stock screens as undervalued on this metric.

Result: UNDERVALUED

P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 20 top founder-led companies.

Upgrade Your Decision Making: Choose your Omega Healthcare Investors Narrative

Earlier it was mentioned that there is an even better way to understand valuation, so Narratives on Simply Wall St help you attach a clear story about Omega Healthcare Investors to the numbers by linking your view on its senior care demand, margins and risk to a financial forecast. This turns that into a fair value you can compare with the current price to decide if the stock looks attractive or stretched. All of this sits inside an easy Community tool that updates as new earnings or news arrive. One investor might build a more optimistic Omega Healthcare Investors Narrative that leans into demographic demand, portfolio expansion and the higher analyst target of US$59.00. Another might focus on tenant credit risk, regulatory pressure and the lower target of US$43.00. Both can then see instantly how their story translates into a different fair value and action plan.

Do you think there's more to the story for Omega Healthcare Investors? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.